WallStSmart
ARTL

Artelo Biosciences Inc

NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY

$3.49
+2.35% today

Updated 2026-04-30

Market cap
$3.79M
P/E ratio
P/S ratio
EPS (TTM)
$-37.56
Dividend yield
52W range
$3 – $86
Volume
4.2M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$18.00
+415.76%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.92M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-10.08M$-9.29M$-9.83M$-12.88M$-4.17M
EPS$-37.56
Free cash flow$-8.01M$-8.21M$-8.35M$-8.52M$-2.92M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ARTL$3.79M264.33.05.05.0Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Artelo Biosciences Inc trades at $3.49. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is Artelo Biosciences Inc's stock price?
Artelo Biosciences Inc (ARTL) trades at $3.49.
Is Artelo Biosciences Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Artelo Biosciences Inc (ARTL)?
The analyst target price is $18.00, representing +415.8% upside from the current price of $3.49.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-1,625.00%
Beta0.41
50D MA$5.04
200D MA$12.96
Shares out0.00B
Float0.00B
Short ratio
Avg volume4.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years